682 results on '"Adelstein, David J."'
Search Results
52. Choice of Radiotherapy Planning Modality Influences Toxicity in the Treatment of Locally Advanced Esophageal Cancer
53. Disease Progression in Cutaneous Squamous Cell Carcinoma Patients With Satellitosis and In-transit Metastasis
54. Oropharyngeal cancer: The role of chemotherapy
55. Transoral resection of pharyngeal cancer: Summary of a National Cancer Institute Head and Neck Cancer Steering Committee Clinical Trials Planning Meeting, November 6–7, 2011, Arlington, Virginia
56. Single-arm phase II study of multiagent concurrent chemoradiotherapy and gefitinib in locoregionally advanced squamous cell carcinoma of the head and neck
57. Head and Neck Cancer
58. Contributors
59. Esophageal Cancer
60. An Imaging Biomarker of Tumor-Infiltrating Lymphocytes to Risk-Stratify Patients With HPV-Associated Oropharyngeal Cancer.
61. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly†‡
62. DEFINITIVE MANAGEMENT OF INOPERABLE NON–SMALL CELL LUNG CANCER
63. Contributors
64. Evaluating compliance with process‐related quality metrics and survival in oral cavity squamous cell carcinoma: Multi‐institutional oral cavity collaboration study
65. Selection of patients for surveillance imaging after radiotherapy for squamous cell carcinoma of oral cavity and oropharynx.
66. Single-institute outcomes of palliative chemotherapy in metastatic head and neck squamous cell carcinoma (HNSCC).
67. Combination of tumor multinucleation and spatial arrangement of tumor-infiltrating lymphocytes to predict overall survival in oropharyngeal squamous cell carcinoma: A multisite study.
68. Computerized features of spatial interplay of tumor-infiltrating lymphocytes predict disease recurrence in p16+ oropharyngeal squamous cell carcinoma: A multisite validation study.
69. Rethinking the 10‐pack‐year rule for favorable human papillomavirus–associated oropharynx carcinoma: A multi‐institution analysis
70. Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization
71. Impact of active smoking on outcomes in HPV+ oropharyngeal cancer
72. Tumor Volume Useful Beyond Classic Criteria in Selecting Larynx Cancers For Preservation Therapy
73. A Phase II Study of Perioperative Concurrent Chemotherapy, Gefitinib, and Hyperfractionated Radiation Followed by Maintenance Gefitinib in Locoregionally Advanced Esophagus and Gastroesophageal Junction Cancer
74. DOCETAXEL, CISPLATIN, AND FLUOROURACIL INDUCTION CHEMOTHERAPY FOLLOWED BY ACCELERATED FRACTIONATION/CONCOMITANT BOOST RADIATION AND CONCURRENT CISPLATIN IN PATIENTS WITH ADVANCED SQUAMOUS CELL HEAD AND NECK CANCER: A SOUTHWEST ONCOLOGY GROUP PHASE II TRIAL (S0216)#
75. Concurrent Chemoradiotherapy
76. Clinical predictors of larynx preservation after multiagent concurrent chemoradiotherapy
77. Role of 18F-FDG PET in Management of Sinonasal Neoplasms
78. Clinical Trials in Advanced Unresectable Head and Neck Cancer
79. Ability of Positron Emission Tomography to Detect Residual Neck Node Disease in Patients With Head and Neck Squamous Cell Carcinoma After Definitive Chemoradiotherapy
80. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma
81. American Society of Clinical Oncology Clinical Practice Guideline for the Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer
82. Does Induction Chemotherapy Have a Role in the Management of Locoregionally Advanced Squamous Cell Head and Neck Cancer?
83. Multiagent Concurrent Chemoradiotherapy for Locoregionally Advanced Squamous Cell Head and Neck Cancer: Mature Results From a Single Institution
84. Induction Redux: Once More With Taxanes
85. Impact of Induction Concurrent Chemoradiotherapy on Pulmonary Function and Postoperative Acute Respiratory Complications in Esophageal Cancer*
86. Endoscopic Ultrasound Errors in Esophageal Cancer
87. Organ Preservation for Advanced Resectable Cancer of the Base of Tongue and Hypopharynx: A Southwest Oncology Group Trial
88. Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma
89. Chemoradiotherapy in Unresectable Squamous Cell Head and Neck Cancer: In Reply
90. Value of accelerated multimodality therapy in stage IIIA and IIIB non–small cell lung cancer
91. Refining esophageal cancer staging
92. Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma
93. An Intergroup Phase III Comparison of Standard Radiation Therapy and Two Schedules of Concurrent Chemoradiotherapy in Patients With Unresectable Squamous Cell Head and Neck Cancer
94. Stage III non–small cell lung cancer and metachronous brain metastases
95. Maximizing Local Control and Organ Preservation in Stage IV Squamous Cell Head and Neck Cancer With Hyperfractionated Radiation and Concurrent Chemotherapy
96. Superficial adenocarcinoma of the esophagus
97. Preoperative Chemoradiotherapy Using Taxanes for Locally Advanced Esophageal Carcinoma
98. N1 esophageal carcinoma: The importance of staging and downstaging
99. Hypothyroidism
100. Enteral nutrition during the treatment of head and neck carcinoma: is a percutaneous gastrostomy tube preferable to a nasogastric tube?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.